XML 41 R29.htm IDEA: XBRL DOCUMENT
v3.25.2

Royalty Monetization Arrangement - Rollforward (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | ---
Jun. 30, 2025 | Jun. 30, 2025 | Jun. 30, 2025
Liability related to future royalties [Roll Forward] |  |  |
Liability related to future royalties - beginning balance |  |  | $ 0
Liability related to future royalties - ending balance | $ 70,260 | $ 70,260 | 70,260
Sagard Healthcare Partners | Royalty Monetization Arrangement |  |  |
Liability related to future royalties [Roll Forward] |  |  |
Liability related to future royalties - beginning balance |  |  | 0
Proceeds from sale of future royalties | 70,000 |  | 70,000
Deferred transaction costs | (300) |  | (327)
Non-cash interest expense recognized |  | 600 | 587
Liability related to future royalties - ending balance | $ 70,260 | $ 70,260 | $ 70,260

X
- Definition Deferred transaction costs + References No definition available. + Details
Name: | mgnx_DeferredTransactionCosts
Namespace Prefix: | mgnx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Liability related to future royalties + References No definition available. + Details
Name: | mgnx_LiabilityRelatedToFutureRoyalties
Namespace Prefix: | mgnx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Liability related to future royalties + References No definition available. + Details
Name: | mgnx_LiabilityRelatedToFutureRoyaltiesRollForward
Namespace Prefix: | mgnx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Proceeds from sale of future royalties + References No definition available. + Details
Name: | mgnx_ProceedsFromSaleOfFutureRoyalties
Namespace Prefix: | mgnx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of interest expense classified as nonoperating. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 220 -SubTopic 40 -Name Accounting Standards Codification -Section 55 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_InterestExpenseNonoperating
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=mgnx_SagardHealthcarePartnersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=mgnx_RoyaltyMonetizationArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |